Jinah Jung
Overview
Explore the profile of Jinah Jung including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
49
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Jang J, Han B, Jung J, Russo P, Kulasekararaj A
BioDrugs
. 2025 Feb;
39(2):281-295.
PMID: 39982653
Eculizumab, a humanized monoclonal antibody targeting complement C5, is the first approved drug for complement-mediated diseases and indicated to treat paroxysmal nocturnal hemoglobinuria, atypical hemolytic uremic syndrome, myasthenia gravis, and...
2.
Girolomoni G, Feldman S, Egeberg A, Puig L, Jung J, Jung H, et al.
J Dermatolog Treat
. 2024 Dec;
35(1):2434091.
PMID: 39626886
Background: SB5 (adalimumab-bwwd) is an adalimumab biosimilar targeting tumor necrosis factor (TNF) for the treatment of chronic inflammatory diseases, including moderate-to-severe chronic plaque psoriasis. Objectives: To assess the four-year persistence...
3.
Han S, Cho Y, Yoon S, Lim K, Cho S, Kim J, et al.
J Clin Endocrinol Metab
. 2020 Dec;
106(3):e1111-e1120.
PMID: 33347565
Objective: To evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of TU2670, a novel orally active, nonpeptide gonadotropin-releasing hormone (GnRH) antagonist administered to healthy female participants. Methods: This was a first-in-human,...
4.
Ghim J, Chin M, Jung J, Lee J, Kim S, Kim B, et al.
J Clin Pharmacol
. 2020 Dec;
61(7):913-922.
PMID: 33341955
This clinical trial was conducted to evaluate the pharmacokinetics and pharmacodynamics of tegoprazan when coadministered with amoxicillin/clarithromycin in healthy subjects. Cohort 1 was an open-label, randomized multiple-dose study to evaluate...
5.
Kim D, Lee D, Ahn S, Jung J, Kiem S, Kim S, et al.
J Clin Pharm Ther
. 2019 Jun;
44(5):750-759.
PMID: 31228353
WHAT IS KNOWN AND OBJECTIVE: Although patients may have received vancomycin therapy with therapeutic drug monitoring (TDM), those treated with high-strength and long-term vancomycin therapy might have unstable and time-varying...
6.
Jung J, Choi S, Cho S, Ghim J, Hwang A, Kim U, et al.
Clin Ther
. 2010 Jul;
32(6):1178-87.
PMID: 20637970
Background: Avanafil is a selective phosphodiesterase type 5 inhibitor being developed for the treatment of erectile dysfunction. Objective: This study was conducted to meet Korean regulatory requirements for the marketing...